In Q2 FY25, LTIMindtree recorded a consolidated net profit of ₹1,251 Crore, up 7.7% from ₹1,161.8 Crore last year.

It further stated that a formal notification recognizing the business as the victorious bidder is expected shortly.

USFDA approved the pharmaceutical company's Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg.

Enviro Infra Engineers Ltd launched its initial public offering (IPO) for subscription on November 22, 2024, and the ...

On Friday, Enviro Infra Engineers’ initial public offering (IPO) became available for subscription. The issue will go up for ...

To satisfy demand worldwide, Japanese apparel company Uniqlo intends to increase production and sourcing in India. Currently, ...

In an interesting speech, RBI governor delves on whether it is possible to consistently balance inflation and growth ...

BEML, which reports to the Ministry of Defence, operates in three verticals: construction and mining, rail and metro, and ...

Nippon Life India Asset Management has announced the signing of a formal deal with One Place Commercials Private Limited to ...

NTPC Green Energy has opened its IPO for subscription from November 19, closes today, on November 22, 2024. This IPO is a ...

The Fed has the leeway to lower interest rates in December since it is taking longer for the unemployed to find new ...

NLC India’s board approved a strategic investment of ₹3,720 crore in its subsidiary, NLC India Renewables Ltd (NIRL), to ...